559 related articles for article (PubMed ID: 6801555)
21. [Intermittent treatment of Paget's disease of bone with calcitonin: histological study].
Eisinger J; Laponche AM
Rev Rhum Mal Osteoartic; 1976; 43(7-9):511-6. PubMed ID: 981933
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of resistant Paget's disease of bone with pamidronate.
Mallette LE
Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
[TBL] [Abstract][Full Text] [Related]
23. [Therapy of Paget's disease of bone].
Ziegler R; Frank K
Dtsch Med Wochenschr; 1988 Jan; 113(3):102-5. PubMed ID: 3123193
[No Abstract] [Full Text] [Related]
24. Paget's bone disease treated with diphosphonate and calcitonin.
Hosking DJ; Bijvoet OL; van Aken J; Will EJ
Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
[TBL] [Abstract][Full Text] [Related]
25. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
Chapuy MC; Meunier P; Terrier M; David L; Vignon G
Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of Paget's disease with salmon calcitonin].
Manderlier T; Fuss M; Brauman J; Orloff S; Bergans A; Corvilain J
Rev Rhum Mal Osteoartic; 1977 Jan; 44(1):59-66. PubMed ID: 319520
[No Abstract] [Full Text] [Related]
28. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
Jaeger P; Bischoff-Delaloye A; Burckhardt P
Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Paget's disease of bone with porcine calcitonin: clinical and metabolic responses.
Kanis JA; Fitzpatrick K; Strong JA
Q J Med; 1975 Jul; 44(175):399-413. PubMed ID: 1101286
[TBL] [Abstract][Full Text] [Related]
31. Effect of calcitonin treatment on the natural course of bone demineralization in Paget's disease.
Toh SH; Claunch BC; Brown PH
J Clin Endocrinol Metab; 1983 Feb; 56(2):405-9. PubMed ID: 6822644
[TBL] [Abstract][Full Text] [Related]
32. [The value of the calcitonin test in Paget's disease of bone].
D'Amore M; Bozzi A; Telesca ML; Carrozzo M
Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
[TBL] [Abstract][Full Text] [Related]
33. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
Caniggia A; Nuti R; Vattimo A; Galli M; Turchetti V; Franci B; Martorelli T; Righi G
Minerva Med; 1983 Apr; 74(18):993-1010. PubMed ID: 6087215
[TBL] [Abstract][Full Text] [Related]
34. One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray.
Reginster JY; Jeugmans-Huynen AM; Albert A; Denis D; Franchimont P
J Bone Miner Res; 1988 Jun; 3(3):249-52. PubMed ID: 3213619
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of Paget's disease with salmon thyrocalcitonin. Cooperative double-blind study].
Bouvet JP
Nouv Presse Med; 1976 Apr; 6(17):1447-50. PubMed ID: 67592
[TBL] [Abstract][Full Text] [Related]
36. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
[No Abstract] [Full Text] [Related]
37. [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate].
Ravault A; Meunier PJ
Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):293-302. PubMed ID: 2496461
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study].
Eisinger J; Laponche AM; Ouaniche J
Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204
[No Abstract] [Full Text] [Related]
39. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
Harinck HI; Bijvoet OL; Blanksma HJ; Dahlinghaus-Nienhuys PJ
Clin Orthop Relat Res; 1987 Apr; (217):79-98. PubMed ID: 2951049
[TBL] [Abstract][Full Text] [Related]
40. The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
Ralston SH; Boyce BF; Cowan RA; Fogelman I; Smith ML; Jenkins A; Boyle IT
J Bone Miner Res; 1987 Feb; 2(1):5-12. PubMed ID: 3137773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
